| Serial Number | 90801633 |
| Word Mark | NEOGENOMICS EUROPE |
| Filing Date | Tuesday, June 29, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 20, 2022 |
| Goods and Services | Pre-packaged medical tests kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of clinical medical reagents and assays for use in disease testing for clinical medical laboratory use |
| Goods and Services | Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; oncology reference laboratory services |
| NOT AVAILABLE | "EUROPE" |
| Goods and Services | Pre-packaged medical tests kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes for use in disease testing for clinical medical laboratory use |
| Goods and Services | Medical research; genetic mapping for scientific purposes, namely, gene sequencing; genetic testing and sequencing for scientific research purposes; molecular sequencing for scientific research purposes; cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells all being for scientific purposes; clinical study and testing of cells for scientific or research purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; medical and scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer; providing scientific information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells for scientific purposes; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for research purposes in the field of human disease and human medical conditions; clinical laboratory research services, oncology reference laboratory services for research and scientific purposes, providing medical research information and interactive scientific research information to others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing cloud-based information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; software as a service (SAAS) services featuring software for use in nucleic acid and protein assay analysis and for quality control, clinical decision support, validation, interpretation, reporting, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to genomic analysis and molecular analysis; providing temporary use of cloud-based non-downloadable computer software providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 11, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 11, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 11, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 11, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Fort Myers, FL 33912 |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Fort Myers, FL 33913 |
| Event Date | Event Description |
| Friday, July 2, 2021 | NEW APPLICATION ENTERED |
| Saturday, September 11, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, March 20, 2022 | ASSIGNED TO EXAMINER |
| Monday, March 28, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, March 28, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, March 28, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 13, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, June 13, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 13, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 27, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 27, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 28, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 16, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 30, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 20, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 20, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, February 1, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 1, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, February 1, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, March 18, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 18, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, February 14, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, August 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, August 10, 2023 | SOU EXTENSION 1 FILED |
| Thursday, August 10, 2023 | SOU EXTENSION 1 GRANTED |
| Saturday, August 12, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |